Recent advances on CD4+ T cells in atherosclerosis and its implications for therapy

No abstract is available for this paper.

• Publication year

  2017

• Venue

  European Journal of Pharmacology

• Publication date

  2017-12-05

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.ejphar.2017.04.029PMID 28457923
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• CD40 in coronary artery disease: a matter of macrophages?

  2016cited by this paper
• Follicular Helper T Cells in Autoimmunity

  2016cited by this paper
• Secukinumab long-term safety experience: A pooled analysis of 10 phase II and III clinical studies in patients with moderate to severe plaque psoriasis.

  2016cited by this paper
• Atherosclerosis-Driven Treg Plasticity Results in Formation of a Dysfunctional Subset of Plastic IFNγ+ Th1/Tregs.

  2016influential reference
• Linking CD11b+ Dendritic Cells and Natural Killer T Cells to Plaque Inflammation in Atherosclerosis

  2016cited by this paper
• Intranasal immunization with heat shock protein 60 induces CD4+CD25+GARP+ and type 1 regulatory T cells and inhibits early atherosclerosis

  2016cited by this paper
• A CD1d-dependent lipid antagonist to NKT cells ameliorates atherosclerosis in ApoE-/- mice by reducing lesion necrosis and inflammation.

  2016cited by this paper
• CCR5+T-bet+FoxP3+ Effector CD4 T Cells Drive Atherosclerosis.

  2016cited by this paper
• Endarterectomy patients with elevated levels of circulating IL-16 have fewer cardiovascular events during follow-up.

  2016cited by this paper
• Overexpression of Cytotoxic T-Lymphocyte–Associated Antigen-4 Prevents Atherosclerosis in Mice

  2016cited by this paper
• Neutrophils license iNKT cells to regulate self-reactive mouse B cell responses

  2016cited by this paper
• Heat‐killed Staphylococcus aureus reduces atherosclerosis by inducing anti‐inflammatory macrophages

  2016cited by this paper
• The Roles of CD137 Signaling in Atherosclerosis

  2016cited by this paper
• Constitutive GITR Activation Reduces Atherosclerosis by Promoting Regulatory CD4+ T-Cell Responses—Brief Report

  2016cited by this paper
• Blockade of Tim-1 and Tim-4 Enhances Atherosclerosis in Low-Density Lipoprotein Receptor–Deficient Mice

  2016cited by this paper
• NKT Cell Hyporesponsiveness Leads to Unrestrained Accumulation of Marginal Zone B Cells in Hypercholesterolemic Apolipoprotein E–Deficient Mice

  2016cited by this paper
• Interleukin-35: a Potential Therapeutic Agent for Autoimmune Diseases

  2016cited by this paper
• Maraviroc Reduces Arterial Stiffness in PI-Treated HIV-infected Patients

  2016cited by this paper
• Interleukin-22: immunobiology and pathology.

  2015influential reference
• Anti-CCL21 Antibody Attenuates Infarct Size and Improves Cardiac Remodeling After Myocardial Infarction

  2015cited by this paper
• Attenuation of early atherosclerotic lesions by immunotolerance with β2 glycoprotein I and the immunomodulatory effectors interleukin 2 and 10 in a murine model.

  2015cited by this paper
• Secukinumab Inhibition of Interleukin-17A in Patients with Psoriatic Arthritis.

  2015cited by this paper
• CD4+ T cell anergy prevents autoimmunity and generates regulatory T cell precursors

  2015cited by this paper
• Expansion of CD25+ Innate Lymphoid Cells Reduces Atherosclerosis

  2015influential reference
• p21WAF1 Is Required for Interleukin-16-Induced Migration and Invasion of Vascular Smooth Muscle Cells via the p38MAPK/Sp-1/MMP-9 Pathway

  2015cited by this paper
• Boosting Cancer Immunotherapy with Anti-CD137 Antibody Therapy

  2015cited by this paper
• Regulatory T cells in atherosclerosis: critical immune regulatory function and therapeutic potential

  2015influential reference
• Clinical efficacy and safety of anti-IL-17 agents for the treatment of patients with psoriasis.

  2015cited by this paper
• IL-17 and Th17 cells in atherosclerosis: subtle and contextual roles.

  2015cited by this paper
• IL-9 aggravates the development of atherosclerosis in ApoE-/- mice.

  2015cited by this paper
• Proteasome-Mediated Reduction in Proapoptotic Molecule Bim Renders CD4+CD28null T Cells Resistant to Apoptosis in Acute Coronary Syndrome

  2015cited by this paper
• Human Carotid Plaques With High Levels of Interleukin-16 Are Associated With Reduced Risk for Cardiovascular Events

  2015cited by this paper
• Plasma IL-5 concentration and subclinical carotid atherosclerosis

  2015cited by this paper
• IL-25 Inhibits Atherosclerosis Development in Apolipoprotein E Deficient Mice

  2015cited by this paper
• CXCL13 antibody for the treatment of autoimmune disorders

  2015cited by this paper
• Mucosal Administration of Collagen V Ameliorates the Atherosclerotic Plaque Burden by Inducing Interleukin 35-dependent Tolerance*

  2015cited by this paper
• IL-22 affects smooth muscle cell phenotype and plaque formation in apolipoprotein E knockout mice.

  2015influential reference
• Artery Tertiary Lymphoid Organs Control Aorta Immunity and Protect against Atherosclerosis via Vascular Smooth Muscle Cell Lymphotoxin β Receptors

  2015cited by this paper
• IL-17A Influences Essential Functions of the Monocyte/Macrophage Lineage and Is Involved in Advanced Murine and Human Atherosclerosis

  2014cited by this paper
• Regulatory T Cells as Immunotherapy

  2014cited by this paper
• CD3 Antibody and IL‐2 Complex Combination Therapy Inhibits Atherosclerosis by Augmenting a Regulatory Immune Response

  2014cited by this paper
• Regression of atherosclerosis with anti-CD3 antibody via augmenting a regulatory T-cell response in mice.

  2014cited by this paper
• Proatherogenic conditions promote autoimmune T helper 17 cell responses in vivo.

  2014cited by this paper
• Molecular and transcriptional basis of CD4⁺ T cell dysfunction during chronic infection.

  2014influential reference
• Control of the T Follicular Helper–Germinal Center B-Cell Axis by CD8+ Regulatory T Cells Limits Atherosclerosis and Tertiary Lymphoid Organ Development

  2014cited by this paper
• Treatment with telmisartan/rosuvastatin combination has a beneficial synergistic effect on ameliorating Th17/Treg functional imbalance in hypertensive patients with carotid atherosclerosis.

  2014cited by this paper
• Induction of T helper 2 responses against human apolipoprotein B100 does not affect atherosclerosis in ApoE-/- mice.

  2014influential reference
• Increased levels of CCR7 ligands in carotid atherosclerosis: different effects in macrophages and smooth muscle cells.

  2014cited by this paper
• Interleukin-10 protects against atherosclerosis by modulating multiple atherogenic macrophage function

  2014cited by this paper
• Circulating Th22 and Th9 Levels in Patients with Acute Coronary Syndrome

  2013cited by this paper
• T-cell co-stimulation by CD28-CD80/86 and its negative regulator CTLA-4 strongly influence accelerated atherosclerosis development.

  2013cited by this paper
• Characterization of CD4+CD28null T cells in patients with coronary artery disease and individuals with risk factors for atherosclerosis.

  2013cited by this paper
• Association between Polymorphisms in IL-16 Genes and Coronary Heart Disease risk

  2013cited by this paper
• A randomized, controlled trial to evaluate the effect of an anti-interleukin-9 monoclonal antibody in adults with uncontrolled asthma

  2013cited by this paper
• Elevated Frequencies of Circulating Th22 Cell in Addition to Th17 Cell and Th17/Th1 Cell in Patients with Acute Coronary Syndrome

  2013cited by this paper
• Interleukin 35: A Key Mediator of Suppression and the Propagation of Infectious Tolerance

  2013cited by this paper
• Efficacy of the CCR5 Antagonist Maraviroc in Reducing Early, Ritonavir-Induced Atherogenesis and Advanced Plaque Progression in Mice

  2013cited by this paper
• T-Helper 2 Immunity Is Associated With Reduced Risk of Myocardial Infarction and Stroke

  2013cited by this paper
• Innate lymphoid cells — how did we miss them?

  2013cited by this paper
• Increased Systemic and Local Interleukin 9 Levels in Patients with Carotid and Coronary Atherosclerosis

  2013cited by this paper
• Interleukin-16 Polymorphism Is Associated with an Increased Risk of Ischemic Stroke

  2013cited by this paper
• Association between interleukin 6 and interleukin 16 gene polymorphisms and coronary heart disease risk in a Chinese population

  2013cited by this paper
• Therapeutic manipulation of natural killer (NK) T cells in autoimmunity: are we close to reality?

  2013influential reference
• Interruption of the OX40–OX40 Ligand Pathway in LDL Receptor–Deficient Mice Causes Regression of Atherosclerosis

  2013influential reference
• Lymphocytic tumor necrosis factor receptor superfamily co-stimulatory molecules in the pathogenesis of atherosclerosis

  2013influential reference
• The association of interleukin-16 gene polymorphisms with susceptibility of coronary artery disease.

  2013cited by this paper
• Depletion of FOXP3+ regulatory T cells promotes hypercholesterolemia and atherosclerosis.

  2013cited by this paper
• High Levels of Costimulatory Receptors OX40 and 4-1BB Characterize CD4+CD28null T Cells in Patients With Acute Coronary Syndrome

  2012influential reference
• Immune Response to Lipoproteins in Atherosclerosis

  2012cited by this paper
• Coronary risk assessment among intermediate risk patients using a clinical and biomarker based algorithm developed and validated in two population cohorts

  2012influential reference
• Cytokine Therapy With Interleukin-2/Anti–Interleukin-2 Monoclonal Antibody Complexes Expands CD4+CD25+Foxp3+ Regulatory T Cells and Attenuates Development and Progression of Atherosclerosis

  2012cited by this paper
• Interleukin-17 deficiency reduced vascular inflammation and development of atherosclerosis in Western diet-induced apoE-deficient mice.

  2012cited by this paper
• Subcutaneous immunization with heat shock protein-65 reduces atherosclerosis in Apoe⁻/⁻ mice.

  2012cited by this paper
• Interleukin-13 protects from atherosclerosis and modulates plaque composition by skewing the macrophage phenotype

  2012cited by this paper
• Interleukin-17A Deficiency Accelerates Unstable Atherosclerotic Plaque Formation in Apolipoprotein E-Deficient Mice

  2012influential reference
• Effector Memory T cells Are Associated With Atherosclerosis in Humans and Animal Models

  2012influential reference
• Regulatory T-Cell Response to Apolipoprotein B100–Derived Peptides Reduces the Development and Progression of Atherosclerosis in Mice

  2012cited by this paper
• Characterisation of IL-22 and interferon-gamma-inducible chemokines in human carotid plaque.

  2012cited by this paper
• Recent Advances on the Role of Cytokines in Atherosclerosis

  2011cited by this paper
• Differential effects of regulatory T cells on the initiation and regression of atherosclerosis.

  2011cited by this paper
• Evidence for a role of regulatory T cells in mediating the atheroprotective effect of apolipoprotein B peptide vaccine

  2011cited by this paper
• Natural killer T cells in lipoprotein metabolism and atherosclerosis

  2011influential reference
• Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity

  2010cited by this paper
• New insights into the development of lymphoid tissues

  2010cited by this paper
• Review of ustekinumab, an interleukin-12 and interleukin-23 inhibitor used for the treatment of plaque psoriasis

  2010cited by this paper
• Intranasal Immunization With an Apolipoprotein B-100 Fusion Protein Induces Antigen-Specific Regulatory T Cells and Reduces Atherosclerosis

  2010cited by this paper
• Blockade of Interleukin-17A Results in Reduced Atherosclerosis in Apolipoprotein E–Deficient Mice

  2010cited by this paper
• CD137 (4–1BB) Deficiency Reduces Atherosclerosis in Hyperlipidemic Mice

  2010cited by this paper
• Mouse Aorta Smooth Muscle Cells Differentiate Into Lymphoid Tissue Organizer-Like Cells on Combined Tumor Necrosis Factor Receptor-1/Lymphotoxin &bgr;-Receptor NF-&kgr;B Signaling

  2010cited by this paper
• Vaccination against Foxp3(+) regulatory T cells aggravates atherosclerosis.

  2010cited by this paper
• Inhibition of IL-17A Attenuates Atherosclerotic Lesion Development in ApoE-Deficient Mice1

  2009cited by this paper
• Identification of IL-17-producing FOXP3+ regulatory T cells in humans

  2009cited by this paper
• Attenuated atherosclerosis upon IL-17R signaling disruption in LDLr deficient mice.

  2009cited by this paper
• Heterogeneity of natural Foxp3+ T cells: A committed regulatory T-cell lineage and an uncommitted minor population retaining plasticity

  2009cited by this paper
• Effect of natural killer T cell activation on initiation of atherosclerosis

  2009cited by this paper
• GATA3 and the T-cell lineage: essential functions before and after T-helper-2-cell differentiation

  2009cited by this paper
• Interleukin 4 inhibits TGF-β-induced-Foxp3+T cells and generates, in combination with TGF-β, Foxp3− effector T cells that produce interleukins 9 and 10

  2008cited by this paper
• IL-33 reduces the development of atherosclerosis

  2008influential reference
• CD137 Is Expressed in Human Atherosclerosis and Promotes Development of Plaque Inflammation in Hypercholesterolemic Mice

  2008cited by this paper
• Interleukin-4 does not influence development of hypercholesterolemia or angiotensin II-induced atherosclerotic lesions in mice.

  2007cited by this paper

• An oxidative stress-related molecular signature in atherosclerosis: identification of risk genes, construction of a diagnostic model, and characterization of immunocyte landscape

  2025cites this paper
• Circulating immune cell landscape and T‐cell abnormalities in patients with moyamoya disease

  2024cites this paper
• Causal relationship between immune cells and risk of myocardial infarction: evidence from a Mendelian randomization study

  2024cites this paper
• Overview of multifunctional Tregs in cardiovascular disease: From insights into cellular functions to clinical implications

  2024cites this paper
• The Role of Bacterial Extracellular Membrane Nanovesicles in Atherosclerosis: Unraveling a Potential Trigger

  2024cites this paper
• Research progress on the active ingredients of traditional Chinese medicine in the intervention of atherosclerosis: A promising natural immunotherapeutic adjuvant.

  2023cites this paper
• Complex Interplay Between Metabolism and CD4+ T-Cell Activation, Differentiation, and Function: a Novel Perspective for Atherosclerosis Immunotherapy

  2023cites this paper
• The emerging role of Th1 cells in atherosclerosis and its implications for therapy

  2023cites this paper
• Metabolic changes with the occurrence of atherosclerotic plaques and the effects of statins

  2023cites this paper
• Novel therapeutic targets and emerging treatments for atherosclerotic cardiovascular disease.

  2023cites this paper
• Targeting gut microbiota and immune crosstalk: potential mechanisms of natural products in the treatment of atherosclerosis

  2023cites this paper
• Executable models of immune signaling pathways in HIV-associated atherosclerosis

  2022cites this paper
• Executable models of pathways built using single-cell RNA seq data reveal immune signaling dysregulations in people living with HIV and atherosclerosis

  2022cites this paper
• The Predictive Value of Different Nutritional Indices Combined with the GRACE Score in Predicting the Risk of Long-Term Death in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention

  2022cites this paper
• Hypercholesterolemic Dysregulation of Calpain in Lymphatic Endothelial Cells Interferes With Regulatory T-Cell Stability and Trafficking

  2022cites this paper
• Mechanistic Insight into PPARγ and Tregs in Atherosclerotic Immune Inflammation

  2021cites this paper
• Interleukin-17-Producing CD4+ T Cells Promote Inflammatory Response and Foster Disease Progression in Hyperlipidemic Patients and Atherosclerotic Mice

  2021influential citation
• The roles of immune cells in atherosclerotic calcification

  2021cites this paper
• Microvesicle signaling in cardiovascular biology under normal and pathobiological conditions

  2021cites this paper
• Key Chemokine Pathways in Atherosclerosis and Their Therapeutic Potential

  2021cites this paper
• Promoting athero-protective immunity by vaccination with low density lipoprotein-derived antigens.

  2021cites this paper
• Difference of immune cell infiltration between stable and unstable carotid artery atherosclerosis

  2021cites this paper
• Modern methods for studying atherosclerosis and coronary artery disease: flow cytometry

  2021cites this paper
• Gynura procumbens ethanol extract and its fractions inhibit Th1, Th2 and Th17 but induce Treg cells differentiation during atherosclerosis development

  2021cites this paper
• Cysteinyl cathepsins in cardiovascular diseases.

  2020influential citation
• Functional subsets of circulating follicular helper T cells in patients with atherosclerosis

  2020cites this paper
• Tc17 CD8+ T cells accumulate in murine atherosclerotic lesions, but do not contribute to early atherosclerosis development

  2020cites this paper
• In vitro effects of azide-containing human CRP isoforms and oxLDL on U937-derived macrophage production of atherosclerosis-related cytokines.

  2020cites this paper
• Tolerogenic vaccines for the treatment of cardiovascular diseases

  2020cites this paper
• IL-17 and IFN-γ Productions by CD4+ T cells and T cell Subsets Expressing NKG2D Associated with the Number of Risk Factors for Cardiovascular Diseases.

  2020cites this paper
• Dyslipidemia and Its Role in the Pathogenesis of Atherosclerotic Cardiovascular Disease: Implications for Evaluation and Targets for Treatment of Dyslipidemia Based on Recent Guidelines

  2019cites this paper
• Immunobiology of Atherosclerosis: A Complex Net of Interactions

  2019cites this paper
• Immune-Inflammation in Atherosclerosis: A New Twist In An Old Tale.

  2019cites this paper
• Atherogenesis in the Carotid Artery with and without Interrupted Blood Flow of Two Hyperlipidemic Mouse Strains

  2019cites this paper
• Targeting Early Atherosclerosis: A Focus on Oxidative Stress and Inflammation

  2019influential citation
• Accelerated Atherosclerosis in Rheumatoid Arthritis: Mechanisms and Treatment.

  2019cites this paper
• The many faces of CD8+ T cells in atherosclerosis

  2018cites this paper
• Deep sequencing of the T cell receptor β repertoire reveals signature patterns and clonal drift in atherosclerotic plaques and patients

  2017cites this paper
• Preface: Pathology and Pharmacology of Atherosclerosis.

  2017cites this paper